My Interprofessional Care Team for Adherence and Research Engagement Disparities
Part of paid clinical trials in Springfield, Massachusetts.
- Sponsor
- University of Arizona
- Study ID
- NCT05470439
- Status
- Recruiting
Conditions
- Hypertension
- Medication Adherence
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- My Interprofessional Care team for Adherence and Research Engagement (MI-CARE) — BEHAVIORALMI-CARE is an innovative, tailored coordinated care intervention by pharmacist-community health worker (CHW) team derived from a previous research and a clinical pilot implementation. MI-CARE will identify and address individual, clinical, social-cultural and structural barriers to medication adherence and hypertension management. MI-CARE consists of an initial individualized needs assessment (Baseline). During Months 1-2, pharmacist-CHW team will deliver a tailored intervention including an individualized medication chart, preferred adherence aids, hypertension therapy optimization, tailored education based on medication beliefs, tools to combat social stressors, and referrals for structural barriers such as food insecurity, transportation and drug costs. Tailored family/care partner participation and telehealth visits will be provided when needed during this time. A booster visit to assess patient progress and reinforce intervention components will occur at Month 2.
Study Details
MI-CARE is an innovative coordinated care team intervention to improve medication adherence and blood pressure derived from research findings that build on existing clinical practice. Designed with an eye toward sustainability, MI-CARE incorporates billable pharmacist and CHW services for patients with low medication adherence and high burdens of chronic illness and preventable consequences. MI-CARE offers interprofessional team care with comprehensive expertise and complementary skill sets that mitigate the silo effect of specialized medicine to deliver primary care to diverse, high-risk populations experiencing disparities in hypertension.
Key Dates
- Start date
- Aug 30, 2023
- Status verified
- Jun 2025
- Primary completion
- Mar 31, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 217 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: MI-CARE InterventionPharmacist-community health worker team providing coordinated care tailored to high-risk patients with hypertension. MI-CARE intervention participants will meet with the pharmacist-CHW team for medication optimization and tailored case management. Pill counts will be completed to assess adherence and BP will be measured at each visit to guide antihypertensive medication optimization and provide feedback to participants about their adherence and BP control. Intervention visits will be followed by a booster one month later.
- No Intervention: Waitlist ControlParticipants enrolled in this arm will receive usual medical care
Primary Outcome Measure
Objectively measured medication adherence (pill count) [ Time Frame: Month 6 ]
Central Contacts
- Vrinda Prakash, MPH413-739-1100
- Susan J Shaw, PhD413-545-7436
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Caring Health Center, Inc. | Springfield | Massachusetts | 01103 | Cristina Huebner Torres, PhD MA (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Springfield, MA
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring DevicesRecruiting · Dynocardia, Inc · Newton, Massachusetts
- Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical StudyPHASE4 · Recruiting · Brigham and Women's Hospital · Boston, Massachusetts